Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hereditas|January 1, 1995
A male-biased natal sex-ratio in inbred collared lemmings, Dicrostonyx groenlandicusG H Jarrell
Biochimica Et Biophysica Acta|January 31, 1992
Oligosaccharide order in a membrane-incorporated complex glycosphingolipidH Jarrell, D Singh, C W Grant
The American Journal of Emergency Medicine|April 7, 2018
Comparison of drug administration logistics between prothrombin complex concentrates and plasma in the emergency departmentSumaiah J Alarfaj, Daniel H Jarrell, Asad E Patanwala
Clinical Toxicology (Philadelphia, Pa.)|July 24, 2018
Comparison of lower-dose versus higher-dose intravenous naloxone on time to recurrence of opioid toxicity in the emergency departmentFelicia Wong, Christopher J Edwards, Daniel H Jarrell, et al.
The Journal of Emergency Medicine|October 9, 2017
Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot StudyMark A Culver, Emily C Richards, Daniel H Jarrell, et al.
Cytogenetics and Cell Genetics|January 1, 1992
Heterosynapsis and axial equalization of the sex chromosomes of the northern bobwhite quailK M Hogan, G H Jarrell, E J Ryder, et al.
Biochimica Et Biophysica Acta|June 27, 1990
Glycosphingolipid interdigitation in phospholipid bilayers examined by deuterium NMR and EPRE Florio, H Jarrell, D B Fenske, et al.
The American Journal of Emergency Medicine|November 12, 2018
Comparison of phenobarbital-adjunct versus benzodiazepine-only approach for alcohol withdrawal syndrome in the EDShannon M Sullivan, Brittney N Dewey, Daniel H Jarrell, et al.
The American Journal of Emergency Medicine|November 22, 2017
Analgosedative interventions after rapid sequence intubation with rocuronium in the emergency departmentEmily Kilber, Daniel H Jarrell, John C Sakles, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 27, 2018
Comparison of blood product use and costs with use of 3-factor versus 4-factor prothrombin complex concentrate for off-label indicationsJessica DeAngelo, Daniel H Jarrell, Richard Cosgrove, et al.
Pageof 1